These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 17606951)

  • 1. The economic burden of chronic cardiovascular disease for major insurers.
    Trogdon JG; Finkelstein EA; Nwaise IA; Tangka FK; Orenstein D
    Health Promot Pract; 2007 Jul; 8(3):234-42. PubMed ID: 17606951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The medical cost of cardiometabolic risk factor clusters in the United States.
    Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
    Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State-level estimates of annual medical expenditures attributable to obesity.
    Finkelstein EA; Fiebelkorn IC; Wang G
    Obes Res; 2004 Jan; 12(1):18-24. PubMed ID: 14742838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer treatment cost in the United States: has the burden shifted over time?
    Tangka FK; Trogdon JG; Richardson LC; Howard D; Sabatino SA; Finkelstein EA
    Cancer; 2010 Jul; 116(14):3477-84. PubMed ID: 20564103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs.
    Daviglus ML; Liu K; Greenland P; Dyer AR; Garside DB; Manheim L; Lowe LP; Rodin M; Lubitz J; Stamler J
    N Engl J Med; 1998 Oct; 339(16):1122-9. PubMed ID: 9770560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State- and payer-specific estimates of annual medical expenditures attributable to obesity.
    Trogdon JG; Finkelstein EA; Feagan CW; Cohen JW
    Obesity (Silver Spring); 2012 Jan; 20(1):214-20. PubMed ID: 21681222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease costs associated with uncontrolled hypertension.
    Flack JM; Casciano R; Casciano J; Doyle J; Arikian S; Tang S; Arocho R
    Manag Care Interface; 2002 Nov; 15(11):28-36. PubMed ID: 12449899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
    Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care expenditure burden of persisting herpes zoster pain.
    Dworkin RH; White R; O'Connor AB; Hawkins K
    Pain Med; 2008 Apr; 9(3):348-53. PubMed ID: 18366512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining costs of chronic conditions in a Medicaid population.
    Garis RI; Farmer KC
    Manag Care; 2002 Aug; 11(8):43-50. PubMed ID: 12232928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Economic burden of coronary heart disease and stroke attributable to hypertension in China].
    Zhai Y; Hu JP; Kong LZ; Zhao WH; Chen CM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):744-7. PubMed ID: 17299955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs of Chronic Diseases at the State Level: The Chronic Disease Cost Calculator.
    Trogdon JG; Murphy LB; Khavjou OA; Li R; Maylahn CM; Tangka FK; Nurmagambetov TA; Ekwueme DU; Nwaise I; Chapman DP; Orenstein D
    Prev Chronic Dis; 2015 Sep; 12():E140. PubMed ID: 26334712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of occupational circulatory disease.
    Leigh JP; Schnall P
    Occup Med; 2000; 15(1):257-67, v. PubMed ID: 10702089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-cost users among dual eligibles in three care settings.
    Yip J; Nishita CM; Crimmins EM; Wilber KH
    J Health Care Poor Underserved; 2007 Nov; 18(4):950-65. PubMed ID: 17982217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic Burden of Chronic Conditions Among Survivors of Cancer in the United States.
    Guy GP; Yabroff KR; Ekwueme DU; Rim SH; Li R; Richardson LC
    J Clin Oncol; 2017 Jun; 35(18):2053-2061. PubMed ID: 28471724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National medical spending attributable to overweight and obesity: how much, and who's paying?
    Finkelstein EA; Fiebelkorn IC; Wang G
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-219-26. PubMed ID: 14527256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
    Noyes K; Liu H; Li Y; Holloway R; Dick AW
    Mov Disord; 2006 Mar; 21(3):362-72. PubMed ID: 16211621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sickness and eligibility levels as factors in health care cost curve.
    Cole DL
    Med Interface; 1996 May; 9(5):54-5. PubMed ID: 10157686
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost of cardiovascular diseases in the United Kingdom.
    Luengo-Fernández R; Leal J; Gray A; Petersen S; Rayner M
    Heart; 2006 Oct; 92(10):1384-9. PubMed ID: 16702172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.